Representation of older adults in randomized controlled trials on systemic treatment in plaque psoriasis: A systematic review.
Psoriasis is frequently seen in older patients and systemic treatment is often indicated. Randomized controlled trials (RCTs) generally maintain strict in- and exclusion criteria, which might lead to a disproportionally high exclusion rate of older adults. To determine the representation of older adults (≥65 years) in RCTs studying systemic treatment in plaque psoriasis. A systematic literature search was performed in PubMed/MEDLINE, EMBASE and CENTRAL, including RCTs concerning systemic treatments in plaque psoriasis in the past 15 years. Direct exclusion (age-limit based) and indirect exclusion (other exclusion criteria) were assessed. Study selection and data extraction was done by two independent reviewers. Of 162 trials reviewed in full, 54 (33.3%) maintained an upper age limit (55-85 years). Of the remaining 108 trials, 106 reported exclusion criteria and did not handle an upper age limit. However, 96 (90.6%) of these trials used exclusion criteria that might unequally affect older adults. The exclusion criteria "serious concurrent infection (n=104; 66.7%)" and "malignancy (n=100; 64.1%)" were most commonly mentioned in the included RCTs. Only published RCTs were included. Older adults might be poorly represented in RCTs studying systemic treatment in plaque psoriasis, due to a high rate of (in)direct exclusion.